BPD app trial halted: what happened?
NCT ID NCT06601907
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested alivis, a smartphone app that teaches coping skills for borderline personality disorder (BPD). It was designed for people aged 18-65 with BPD, who used the app alongside their usual treatment. The goal was to see if the app reduces BPD symptoms, depression, and anxiety. However, the trial was terminated early, so we don't have clear results on its effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- alivis digital health application
- What this could lead to
- If it had succeeded, this could point toward a convenient, app-based way to help manage BPD symptoms alongside usual care.
- What could go wrong
- The trial was terminated early, so results are not available. Digital interventions may not work for everyone, and this was an unguided program.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER (BPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
GAIA
Hamburg, 22085, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain zaps and therapy: a new combo to tame BPD emotions
- Gender's role in BPD: a new study seeks answers
- Could ketamine ease severe BPD symptoms? new pilot study aims to find out
- Can writing about trauma in a group ease PTSD for those with BPD traits?
- Can ketamine plus therapy curb suicidal thoughts? new trial aims to find out.
- New study links menstrual cycle to emotional struggles in autistic women